This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Symbiota™ 901 | Metabolic & Glucose Control
Natural GLP-1 Activator & Metabolic Microbiome Regulator
Regulate Metabolism at the Microbiome Level
Symbiota™ 901 is an advanced multi-strain postbiotic ingredient engineered to target the gut-metabolic axis. By utilizing precision symbiotic fermentation, it delivers bioactive metabolites that naturally stimulate metabolic signaling pathways, offering a cutting-edge solution for glucose control and insulin sensitivity.
Core Mechanisms & Clinical Highlights
- Natural GLP-1 Stimulation: Clinical data demonstrates a significant increase in GLP-1 secretion compared to the control group, effectively supporting glucose homeostasis and appetite regulation.
- HbA1c Stabilization: Proven efficacy as a complementary metabolic strategy in human trials, where 75% of metformin-resistant individuals successfully showed stable or reduced HbA1c levels.
- Targeted IMP Reduction: Formulated to regulate IMP-related metabolic pathways, shown to decrease Imidazole Propionate (IMP) by 52%—a critical microbial marker linked to insulin resistance—making it the premier metabiotic ingredient for metabolic syndrome management.